cjc-1295 ipamorelin for anti-aging benefits mechanism Before and After Results CJC-1295 (Mod GRF 1-29) &
Description
Saka, Y
Studies suggest that AOD9604 does not bind the growth hormone receptor and does not activate the JAK2/STAT5 pathway, which accounts for the absence of growth-promoting or IGF-1-elevating effects observed in animal studies
For example, I have seen it clear up psoriasis, eczema, and joint pain
Clinical trials have shown progressive visceral fat reduction over 26-52 weeks of treatment
2025 Jul 30;16(1):6996
Cysteine levels after different treatments were compared after normalization to cell numbers
